Pacira BioSciences falls on Q1 profit miss

Pacira Biosciences

03/05/2023 18:24

** Shares of drug developer Pacira BioSciences Inc  PCRX.O  down 7.43% at $3.45
    ** Co reports adjusted profit of 53 cents per share, below analysts' estimates of 62 cents
per share - Refinitiv data
        ** Co posts revenues of $160.3 mln vs est of $158.8 mln 
  
    ** Brokerage Jefferies says "we believe the mixed financial results taken together with the
co reiterating guidance, investors will view the qtr as modestly disappointing" 
    ** PCRX stock up 11.40% YTD

 (Reporting by Rupali Chaudhary in Bengaluru)
 ((Rupali.chaudhary@thomsonreuters.com))